Viewing Study NCT00383760

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:16 AM

Ignite Modification Date: 2025-12-26 @ 5:42 PM

Study NCT ID: NCT00383760

Status: COMPLETED

Last Update Posted: 2017-10-20

First Post: 2006-09-29

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients

Sponsor: National Cancer Institute (NCI)

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module